| Literature DB >> 34118203 |
Seda Kilinc1, Rebekka Paisner2, Roman Camarda3, Suprit Gupta4, Olga Momcilovic2, Rebecca A Kohnz5, Baris Avsaroglu2, Noelle D L'Etoile2, Rushika M Perera6, Daniel K Nomura5, Andrei Goga7.
Abstract
Oncogenes can alter metabolism by changing the balance between anabolic and catabolic processes. However, how oncogenes regulate tumor cell biomass remains poorly understood. Using isogenic MCF10A cells transformed with nine different oncogenes, we show that specific oncogenes reduce the biomass of cancer cells by promoting extracellular vesicle (EV) release. While MYC and AURKB elicited the highest number of EVs, each oncogene selectively altered the protein composition of released EVs. Likewise, oncogenes alter secreted miRNAs. MYC-overexpressing cells require ceramide, whereas AURKB requires ESCRT to release high levels of EVs. We identify an inverse relationship between MYC upregulation and activation of the RAS/MEK/ERK signaling pathway for regulating EV release in some tumor cells. Finally, lysosome genes and activity are downregulated in the context of MYC and AURKB, suggesting that cellular contents, instead of being degraded, were released via EVs. Thus, oncogene-mediated biomass regulation via differential EV release is a new metabolic phenotype.Entities:
Keywords: AURKB; ESCRT; EVs; HRAS; MYC; ceramide; extracellular vesicles; lysosome; miRNAs; oncogenes
Mesh:
Substances:
Year: 2021 PMID: 34118203 PMCID: PMC8292920 DOI: 10.1016/j.devcel.2021.05.014
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 13.417